Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07454824 · ClinicalTrials.gov registry record · NA
e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most
A NA study, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07454824: Recruiting NA study, sponsored by Johns Hopkins University.
NCT07454824 is a NA study that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07454824, a NA study, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The overarching goal of this study is to pilot an intervention in which older adults with mild cognitive impairment and dementia and the older adult's care partners are identified in primary care and provided with educational materials through the patient portal to engage the participant in deprescribing. The multicomponent intervention, e-Align, includes delivery of educational information through the patient portal, and a pharmacist-led intervention to align medications with patient and care partner goals and reduce use of central nervous system (CNS) potentially inappropriate medicines (PIM). This work will establish the preliminary data, methods, and partnerships to undertake a multisite embedded pragmatic clinical trial. The resulting triadic-based behavioral intervention will promote patient and care partner engagement, and foster care that aligns with patients' values, and promote improved health and well-being outcomes for people with cognitive impairment and the patient's care partners through deprescribing.
Interventions
- OTHER e-ALIGN Patient-Portal Deprescribing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-04-15 |
| Est. Completion | 2027-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07454824
The ClinicalTrials.gov registry entry for NCT07454824 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which e-ALIGN Patient-Portal Deprescribing is the first listed.
NCT07454824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07454824 about?
NCT07454824 is a clinical study titled "e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most". The overarching goal of this study is to pilot an intervention in which older adults with mild cognitive impairment and dementia and the older adult's care partners are identified in primary care and provided with educational materials through the patient portal to engage the participant in deprescr...
What is the current status of trial NCT07454824?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-04-15. Estimated completion is 2027-02-06.
What interventions are being tested in trial NCT07454824?
The interventions under investigation include: e-ALIGN Patient-Portal Deprescribing (OTHER).
Who is sponsoring clinical trial NCT07454824?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.